Track TSHA and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
TSHA - Taysha Gene Therapies Inc (TSHA) has a earnings per share of -$0.11, down 37.5% over the past year.
Latest EPS (Actual)
-$0.11
Beat Rate
50.0%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.10 | -$0.11 | Miss | -10.00% |
| Mar 2026 | -$0.10 | -$0.07 | Beat | +23.43% |
| Nov 2025 | -$0.09 | -$0.09 | Meet | +0.00% |
| Aug 2025 | -$0.07 | -$0.08 | Miss | -14.29% |
| May 2025 | -$0.08 | -$0.08 | Meet | +0.00% |
| Feb 2025 | -$0.08 | -$0.07 | Beat | +12.50% |
| Nov 2024 | -$0.09 | -$0.07 | Beat | +22.22% |
| Aug 2024 | -$0.10 | -$0.09 | Beat | +10.00% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.